Sign up to our newsletter Subscribe
Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries

We have established an excellent reputation for leading innovative, ideas-driven, and theoretically sound research on the measurement and valuation of outcomes. Health care systems should put patient-relevant outcomes at the heart of decisions about funding and providing health and social care.